Inside Nursing Homes’ Smarter Infection Control, Efforts to Curb Antibiotic Overuse

Why It Matters

Inappropriate antibiotic use fuels resistance and adverse events, jeopardizing patient safety and increasing healthcare costs. Integrated stewardship and infection control programs can reduce misuse, improve outcomes, and align facilities with evolving federal expectations.

Key Takeaways

• 70% of nursing home residents receive antibiotics each year
• 40% of those prescriptions are inappropriate in choice, dose, or duration
• Integrated infection control and stewardship improve data-driven antibiotic use
• Point prevalence metric offers quick snapshot of facility antibiotic burden
• Certified infection preventionists and medical directors correlate with better outcomes

Pulse Analysis

Antibiotic overuse in long‑term care has become a national safety concern. Federal data reveal that seven out of ten nursing‑home residents are prescribed antibiotics annually, yet nearly half of those courses are suboptimal in drug selection, dosage, or duration. This misuse not only drives antimicrobial resistance but also precipitates complications such as Clostridioides difficile infections and unnecessary hospitalizations, inflating costs for both providers and payers. Recent regulatory updates now link infection‑control citations with antimicrobial‑stewardship requirements, signaling a shift toward unified oversight.

Effective stewardship in nursing homes hinges on robust data collection and interpretation. Facilities are adopting metrics like infection rates per 1,000 resident days, therapy‑day counts, and especially point prevalence—a rapid snapshot of the proportion of residents on antibiotics at a given moment. While a national benchmark database remains absent, self‑benchmarking and peer collaborations enable homes to gauge performance against regional peers. Training interdisciplinary teams to analyze these metrics, coupled with the deployment of certified infection preventionists and board‑certified medical directors, has been shown to improve prescribing appropriateness and reduce infection‑related adverse events.

Looking ahead, the sector is poised to benefit from emerging federal initiatives aimed at standardizing stewardship reporting and fostering data sharing across networks. Partnerships between government agencies, academic institutions, and private entities, like those championed by CIMPAR, are expanding educational outreach and toolkits tailored to long‑term care settings. As homes integrate infection control and antimicrobial stewardship under a single governance framework, they can more readily meet quality‑measure expectations, protect vulnerable residents, and mitigate the broader public‑health threat of antibiotic resistance.